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Abstract 
The alkaloidal fraction (AFCP) of roots of Cissampelos pareira Linn. was 
screened for in-vitro antioxidant activity and immunomodulatory activity in mice. 
The HPTLC finger print profile was also established for the identification of 
AFCP which was found to contain 0.176 % of berberine. AFCP possess strong 
antioxidant activity which was revealed by its ability to scavenge the stable free 
radical DPPH, superoxide ion and to inhibit lipid peroxidation in rat liver 
homogenate induced by iron/ADP/Ascorbate complex. AFCP was found to have 
significant immunosuppressive activity at lower doses (25 and 50 mg/kg) while 
no activity was observed at higher doses (75 and 100 mg/kg). Humoral antibody 
titre was significantly (p<0.01) lowered by AFCP at the doses of 25 and 50 
mg/kg. Delayed type hypersensitivity response was also significantly (p<0.01) 
suppressed by the AFCP at the dose of 75 mg/kg. Thus the present study 
revealed the immunosuppressive and antioxidant activities of the alkaloidal 
fraction of C. pareira roots. 
Keywords 
Alkaloidal fraction • Humoral antibody titre • Superoxide • Lipid peroxidation • Cissampelos 
pareira Linn. 
 22  A. Bafna and S. Mishra:   
Sci Pharm. 2010; 78; 21–31. 
Introduction 
Immunomodulation using medicinal plants, especially ‘rasayana’ drugs, can provide an 
alternative to conventional chemotherapy for a variety of diseases, especially when the 
host defense mechanism has to be activated under the conditions of impaired immune 
response or when a selective immunosuppression is desired in situations like autoimmune 
disorders. This concept of using rasayanas for health, gained little more credibility, when it 
was realized that herbal antioxidants concurrently exhibit significant immunomodulatory 
activities, like Shilajit and Chyavanprash Awaleha [1]. Further, Indian medicinal plants are 
a rich source of substances which are claimed to induce innate immunity, the non-specific 
immunomodulation of essentially granulocytes, macrophages, natural killer cells and 
complement functions [2].  
About 34 plants are identified as rasayanas in Indian Ayurvedic system of medicine having 
various pharmacological properties such as immunostimulant, tonic, neurostimulant, 
antiageing, antibacterial, antiviral, antirheumatic, anticancer, adaptogenic, antistress, 
antioxidant etc. Many plants with potential immunomodulatory and antioxidant activities 
are reported, some of these have already been undertaken for evaluation of their activities 
in animals, and also to some extent in humans. Some glaring examples with promising 
activity are Asparagus racemosus, Azadirachta indica, Curcuma longa, Ocimum sanctum, 
Panax ginseng, Picrorrhiza kurroa, Tinospora cordifolia, Withania somnifera etc. A lot 
more are still to be explored and offer scope for further investigation [3]. 
Cissampelos pareira Linn. (Menispermaceae) is a climbing shrub distributed throughout 
warm parts of Asia, East Africa, and America. The roots are used as a diuretic and 
febrifuge, as a remedy for heart trouble, dysentery and soares [4]. Furthermore, the roots 
are also used to prevent a threatened miscarriage and the herb is used to stop uterine 
hemorrhage [5]. A novel tropoloisoquinoline alkaloid named pareirubrine A was reported 
for antileukemic activity [6]. Pradhan et al carried out pharmacological and clinical studies 
on hayatin methiodide from C. pareira for its muscle relaxant properties [7]. Basu et al 
reported curare like activity of hyatinin methochloride from C. pareira [8]. Cissamperine 
and other four bisbenzylisoquinoline alkaloids isolated from C. pareira were found to show 
significant and reproducible inhibitory activity against human carcinoma of the 
nasopharynx cell culture (KB) [9].  
The roots of this plant are mainly incorporated into many traditional Ayurvedic formulation 
prescribed for diseases like rheumatism, ulcers, fevers etc. Our earlier work reported the 
immunomodulatory activity of methanol extract of C. pareira [10]. Alkaloids from roots of 
this plant were mainly screened for various pharmacological activities and in order to 
correlate immunomodulatory activity with alkaloids the present work was aimed at studying 
effect of alkaloidal fraction of C. pareira on immune system as well as its ability to 
scavenge free radicals.  
Results and Discussion 
Present investigation was undertaken to mainly evaluate the antioxidant and 
immunomodulatory activities of one of the rasayana drug C. pareira using some reported 
methods.   Antioxidant and Immunomodulatory Activity of Cissampelos pareira Linn.  23 
Sci Pharm. 2010; 78; 21–31. 
In-vitro antioxidant activity 
Free radical scavenging activity of the AFCP was evaluated using different models. 
Inhibition of lipid peroxidation in rat liver homogenate was also evaluated. Table 1 shows 
the DPPH scavenging effect of AFCP. AFCP showed a concentration dependent 
antiradical activity by inhibiting DPPH radical with an IC50 value of 63.44 μg/mL. This 
activity was comparable to the standard curcumin, which showed an IC50 at 52.71 μg/mL.  
Tab. 1.   Antiradical activity of AFCP observed with DPPH. 
Samples Concentration 
(μg/mL) 
% inhibition  IC 50 
(μg/mL) 
20  24.35 ± 2.37 
40  36.34 ± 1.23 
60  53.98 ± 3.54 
80  59.70 ± 1.89 
Alkaloidal fraction 
100  66.39 ± 2.05 
63.44 
Curcumin   52.71 
Values are mean ± S.E.M. of three replicate analyses. 
 
AFCP was also found to scavenge the superoxide radical generated in riboflavin-NBT-light 
system in-vitro and IC50 value was found to be 31.99 μg/mL. It was less potent than the 
standard ascorbic acid which showed an IC50 of 23.52 μg/mL (Table 2). 




% inhibition  IC 50 
(μg/mL) 
10  14.54 ± 1.59 
20  35.62 ± 2.29 
30  48.69 ± 1.99 
40  62.35 ± 2.54 
Alkaloidal fraction 
50  74.28 ± 1.16 
31.99 
Ascorbic acid    23.52 
Values are mean ± S.E.M. of three replicate analyses. 
 
In the present study AFCP showed moderate inhibition of lipid peroxidation induced by 
Iron/ADP/Ascorbate complex in rat liver homogenate. The IC50  value was found to be 
61.85 μg/mL and 30.05 μg/mL for AFCP and standard ascorbic acid respectively (Table 3). 
AFCP showed a dose dependent inhibition of lipid peroxidation.  
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Tab. 3.   Inhibition of lipid peroxidation induced by iron/ADP/ascorbate system in rat liver 
homogenate by AFCP. 
Samples Concentration 
(μg/mL) 
% inhibition  IC 50 
(μg/mL) 
25  25.38 ± 2.55 
50  45.67 ± 1.96 
75  60.24 ± 2.89 
100  75.02 ± 2.22 
Alkaloidal fraction 
 
125  80.29 ± 3.57 
61.85 
Ascorbic acid    30.05 
Values are mean ± S.E.M. of three replicate analyses. 
 
The participation of reactive oxygen species in etiology and physiopathology of human 
diseases, such as neurodegenerative disorders, inflammation, viral infection, autoimmune 
pathologies and digestive system disorders such as gastrointestinal inflammation and 
gastric ulcers is already evident. To understand the role of these reactive oxygen species 
in several disorders and potential antioxidant protective effect of natural compounds on 
affected tissues are topics of high current interest. Initially it is necessary to investigate in-
vitro antioxidant properties of any natural product or drug to consider it as an antioxidant 
substance, followed by evaluation of its antioxidant function in biological systems [11]. 
AFCP showed strong in vitro antioxidant activity in tested models viz., scavenging of 
DPPH and superoxide radicals and inhibition of lipid peroxidation induced by 
Iron/ADP/Ascorbate complex in rat liver homogenate.  
Tetrandrine [12] and berberine [13] were previously isolated from C. pareira roots. They 
were also reported for their antioxidant activity in various models [14, 15]. AFCP was found 
to contain 0.176 % of berberine and activity of AFCP may be due to presence of these two 
with other alkaloids. This antioxidant activity of the AFCP may be responsible for various 
biological activities of the drug, including proposed immunosuppressive activity. 
Immunomodulatory activity 
Recently, many isoquinoline alkaloids are under intensive study for their antimicrobial, anti-
tumor, neuropharmacological and immunosuppressive action. Some of them are already in 
clinical use and it is of interest to investigate their possible effect on the immune system 
[16]. 
The effect of AFCP was tested on humoral and cell-mediated immunity by measuring 
haemagglutination antibody titre and DTH response respectively. The effect was tested at 
four different dose levels ranging from 25 to 100 mg/kg.  
Results obtained during present investigation showed significant (p<0.01) reduction in 
antibody production in response to SRBCs at doses 25 and 50 mg/kg. With further 
increase in dose AFCP had no suppressive effect on antibody production and values 
obtained were more or less equal to control animals (Table 4).    Antioxidant and Immunomodulatory Activity of Cissampelos pareira Linn.  25 
Sci Pharm. 2010; 78; 21–31. 
Suppression of production of antibodies by AFCP at lower doses was comparable to 
positive control cyclophosphamide. The positive control group showed significant (p<0.01) 
reduction of antibody production.  
AFCP when administered orally showed a linear dose dependent decrease in DTH 
response up to 75 mg/kg, however statistically significant decrease could be obtained at 
75 mg/kg dose (p<0.01). At 100 mg/kg of the AFCP the DTH response was slightly 
increased (Table 4). The positive control, cyclophosphamide group showed increased 
DTH response when compared to control group.  
Tab. 4.   Effect of AFCP on humoral antibody titre and DTH response. 
Treatment   Dose 
(mg/kg) 
HA Titre 
(Mean ± S.E.M.) 
DTH 
(Mean ± S.E.M.) 
Control  –  149.33 ± 35.70  0.38 ± 0.08 
CP  50    10.00 ±   2.68**  1.07 ± 0.10** 
25      5.00 ±   1.00**  0.31 ± 0.01
NS 
50      8.00 ±   1.79**  0.23 ± 0.02
NS 
75    64.00 ± 14.31
NS  0.15 ± 0.04** 
Alkaloidal fraction 
100  133.33 ± 40.83
NS  0.27 ± 0.02
NS 
F value    7.30  4.01 
P value    <0.0005  <0.012 
Values are expressed as mean ± SEM.  
Control group was compared with Cyclophosphamide (CP) group and AFCP treated 
groups. 
* p<0.05; ** p<0.01; NS = Non Significant 
 
The present results indicated that AFCP was an effective modulator of both T and B cell 
mediated immune response. The antibody production to T-dependent antigen SRBCs 
requires the co-operation of T and B-lymphocytes and macrophages [17]. Results obtained 
during present investigation showed significant suppressive effect on antibody production 
in response to SRBCs at lower doses of the AFCP, whereas no further decrease was 
noted with increase in doses i.e. at higher doses no effect on HA titre was noted.  
DTH is antigen specific and causes erythema and induction at the site of antigen infection 
in immunized animals. T-cells are required to initiate the reaction. The histology of DTH 
can be different for different species, but the general characteristics are an influx of 
immune cells at the site of injection, macrophages and basophils in mice and induction 
becomes apparent within 24–72 hours [18]. 
Treatment with cyclophosphamide showed reduced humoral antibody titre and 
enhancement of DTH. Cyclophosphamide has a particularly intense effect on short lived 
lymphocytes known to include a great proportion of B-cells [19]. 
C. pareira mainly contains bisbenzoylisoquinoline alkaloids. In more recent research, the 
bisbenzylisoquinoline alkaloids have been found to be anti-inflammatory constituents of C. 
pareira. In clinical experiments, the alkaloids suppressed the production of nitric oxide, a 
critical mediator in inflammation, which explain some aspects of the anti-inflammatory 26  A. Bafna and S. Mishra:   
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mechanisms present in the alkaloids of C. pareira [20]. Results obtained were in 
accordance with this. AFCP suppressed DTH response in a dose dependent manner.  
In the past few years high performance thin layer chromatography has emerged as a 
potential tool for rapid and useful phytochemical evaluation of herbal drugs [21]. 
Establishment of HPTLC fingerprint profile for the AFCP would help to identify this fraction 
of C. pareira. 
Thus from the present study, it can be concluded that AFCP has a strong in vitro 
antioxidant activity and also possess immunosuppressive activity. 
Material and Methods 
Plant material 
Roots of C. pareira Linn. were collected from outfield of Baroda city, Gujarat, India. They 
were authenticated in the Botany Department of M. S. University, Baroda and voucher 
specimen was submitted there. 
Preparation of alkaloidal fraction (AFCP) 
Air dried roots were subjected to extraction with methanol by maceration for 72 hours. 
Yield obtained was 7.75 % (w/w). This methanol extract was utilized for preparation of 
alkaloidal fraction. Methanol extract was acidified with 150 mL of 5% hydrochloric acid and 
left overnight at room temperature. The insoluble non-alkaloid material was removed by 
filtration. The filtrate was subjected to ethyl ether extractions to eliminate the rest of the 
non-alkaloid substances. The residues obtained after evaporation of ether extracts were 
added to non-alkaloid fraction. The acidic solution thus purified was then alkalized with 
25% ammonium hydroxide and extracted with chloroform (6x 200 mL). The evaporation of 
the combined chloroform extracts gave alkaloidal fraction (AFCP), which was further used 
for screening antioxidant activity and immunomodulatory activities.  
Animals 
Swiss albino mice of either sex, weighing 20–25 g, housed in standard conditions of 
temperature, humidity and light were used. They were fed with standard rodent diet and 
water ad libitum. Albino rats of either sex, weighing 150–180 g, for preparation of liver 
homogenate. 
Drugs 
Weighed quantity, 50 mg/10 mL of AFCP was suspended in 1% sodium carboxy 
methylcellulose to prepare suitable dosage form. The control animals were given an 
equivalent volume of sodium carboxy methylcellulose vehicle.  
Antigen: Fresh blood was collected from sheep which were sacrificed in local 
slaughterhouse.  
Sheep red blood cells (SRBC) were washed three times in normal saline and adjusted to a 
concentration of 20% for immunization and 1% for challenge. 
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HPTLC finger print profile of AF and quantitative analysis of berberine  
HPTLC finger print profile was established for AFCP of C. pareira using CAMAG-HPTLC. 
A stock solution (1mg/mL) of AFCP was prepared in methanol. Standard berberine 
solution (0.1 mg/mL) was also prepared in methanol. Calibration curve was obtained for 
10, 20, 30 and 40 ng concentrations of berberine. The solvent system used was n- 
butanol: glacial acetic acid: water (6:2:2). The plates were scanned using TLC Scanner 3 
(CAMAG) at 366 nm (fluorescence/reflectance mode)  
 
Fig. 1.   Chromatogram of standard berberine and AFCP.  
   
(a) (b) 
Fig. 2.   Photograph of berberine and AFCP at 366 nm (a) and with dragendorff’s 
reagent (b).  28  A. Bafna and S. Mishra:   
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HPTLC finger print profile was established for AFCP of C. pareira using CAMAG-HPTLC. 
A stock solution (1 mg/mL) of AFCP was prepared in methanol. Standard berberine 
solution (0.1 mg/mL) was prepared in methanol. Calibration curve was obtained for 10, 20, 
30 and 40 ng concentration of berberine. The solvent system used was n-butanol: glacial 
acetic acid: water (6:2:2). The plates were scanned using TLC Scanner 3 (CAMAG) at 366 
nm (fluorescence/reflectance mode) and after spraying Dragendorff’s reagent at 520 nm. 
Berberine was detected in AF at Rf value 0.70. Chromatogram and peak areas of resolved 
bands were recorded and photographs were taken (Fig. 1). Concentration of berberine in 
sample found was 0.1763 % and after spraying Dragendorff’s reagent at 520 nm. 
Berberine was detected in AFCP at Rf value of 0.70. Chromatogram and peak areas of 
resolved bands were recorded and photographs were taken (Fig. 1). The concentration of 
berberine in sample was found to be 0.1763 % w/w.  
Methods 
In-vitro antioxidant activity 
Assay for antiradical activity with DPPH 
Antiradical activity was measured by a decrease in absorbance at 516 nm of a methanolic 
solution of colored 1,1-diphenyl-2-picrylhydrazine brought about by sample. A stock 
solution of DPPH was prepared by dissolving 4.4 mg in 3.3 mL methanol. Test medium 
includes 150 μL of DPPH solution along with different concentration (20, 40, 60, 80 and 
100 μg/ mL) of samples in 3 mL methanol. Blank was performed in the same way with no 
sample added. Decrease in absorbance, in presence of sample was noted after 15 
minutes. An IC50 was calculated as the concentration which brought about a 50% reduction 
in absorbance compared to blank [22]. 
Assay for superoxide radical scavenging activity 
The assay was based on capacity of the sample to inhibit blue formazon formation by 
scavenging the superoxide radicals generated in riboflavin-light-nitro blue tetrazolium 
(NBT) system. The reaction medium contains 2.5 mL of phosphate buffer (pH 7.6), 100 μL 
riboflavin (20 μg), 200 μL EDTA (12mM), 100μL NBT (0.1 mg) and different concentrations 
(10, 20, 30, 40 and 50 μg/ mL) of sample contained in 100 μL of methanol. The reaction 
was started by illuminating the reaction mixture for 5 minutes. The absorbance was 
measured at 590 nm. Blank was performed in the same way with 100 μL of methanol 
instead of test substance. An IC50  was calculated as the concentration which brought 
about a 50% reduction in absorbance compared to blank [23]. 
Measurement of effect on lipid peroxidation on rat liver homogenate 
Rat liver homogenate was prepared by homogenizing the tissue in chilled Tris buffer 
(10 mM, pH 7.4) at a concentration of 10% w/v. Lipid peroxidation was induced in the liver 
homogenate by Iron-ADP complex in the presence of ascorbic acid. The incubation 
medium constituted of 0.5 mL of the liver homogenate (10% w/v), 100 µM FeCl3, 1.7 µM 
ADP, 500 µM of ascorbate and different concentrations of samples in 2 mL of total 
incubation medium. The medium was incubated for 20 min. at 37°C. Extent of lipid 
peroxidation was determined by estimation of malondialdehyde (MDA) content. Results 
were expressed in terms of decrease in MDA formation by the sample extract. Ascorbic 
acid was used as the positive control [24].   Antioxidant and Immunomodulatory Activity of Cissampelos pareira Linn.  29 
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Immunomodulatory activity 
Humoral antibody (HA) response  
Animals were divided into 6 groups of six animals each. Animals in treatment the groups 
were given the AFCP (25-100 mg/kg, p.o.) in 1.0 % sodium carboxy methyl cellulose daily 
for 7 days. Animals in positive control group received 50 mg/kg of cyclophosphamide (CP) 
for days 4 to 6. The animals were immunized by injecting 0.1 mL of 20% of fresh sheep 
red blood cells suspension intraperitonially on day 0. Blood samples were collected in 
micro centrifuge tubes from individual animal by retro-orbital plexus on day 7. Blood 
samples were centrifuged to obtain serum. Antibody levels were determined by 
haemagglutination technique. The reciprocal of the highest dilution of the test serum which 
caused agglutination was taken as the antibody titre [25]. 
Delayed type hypersensitivity (DTH) response  
Animals were divided into 6 groups of six animals each. Animals in treatment groups were 
given the AFCP (25-100 mg/kg, p.o.) in 1.0 % sodium carboxy methyl cellulose daily for 7 
days. Animals in positive control group received cyclophosphamide (CP) 50 mg/kg for day 
4 to 6. The animals were immunized by injecting 0.1 mL of 20% of fresh sheep red blood 
cells suspension intraperitonially on 0 day. On day 7, the thickness of the right hind foot 
pad was measured using digital vernier caliper. The mice were then challenged by 
injection of 20 µL of 1% SRBCs in right hind foot pad. Foot thickness was again measured 
24  hrs after this challenge. The difference between the pre and post challenge foot 
thickness expressed in mm was taken as a measure of DTH [25].  
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